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TARP -2 Is Required for Inflammation-Associated AMPA
Receptor Plasticity within Lamina II of the Spinal Cord
Dorsal Horn
XSteve J. Sullivan, XMark Farrant, and XStuart G. Cull-Candy
Department of Neuroscience, Physiology and Pharmacology, University College London, LondonWC1E 6BT, United Kingdom
In the brain, transmembraneAMPARregulatory proteins (TARPs) critically influence the distribution, gating, andpharmacology ofAMPARs,
but the contribution of these auxiliary subunits to AMPAR-mediated signaling in the spinal cord remains unclear. We found that the Type I
TARP-2 (stargazin) ispresent in lamina IIof the superficial dorsalhorn, anarea involved innociception.Consistentwith thenotion that-2 is
associated with surface AMPARs, CNQX, a partial agonist at AMPARs associated with Type I TARPs, evoked whole-cell currents in lamina II
neurons, but such currentswere severely attenuated in-2-lacking stargazer (stg/stg)mice. Examination of EPSCs revealed the targeting of-2
tobe synapse-specific; the amplitudeof spontaneously occurringminiatureEPSCs (mEPSCs)was reduced inneurons from stg/stgmice, but the
amplitudeof capsaicin-inducedmEPSCs fromC-fiber synapseswasunaltered. This suggests that-2 is associatedwithAMPARsat synapses in
lamina II but excluded from those at C-fiber inputs, a view supported by our immunohistochemical colabeling data. Following induction of
peripheral inflammation, amodel of hyperalgesia, there was a switch in the current-voltage relationships of capsaicin-inducedmEPSCs, from
linear to inwardly rectifying, indicating an increased prevalence of calcium-permeable (CP) AMPARs. This effect was abolished in stg/stgmice.
Our results establish that, although-2 is not typically associatedwith calcium-impermeableAMPARsatC-fiber synapses, it is required for the
translocation of CP-AMPARs to these synapses following peripheral inflammation.
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Introduction
AMPA-type glutamate receptors (AMPARs) mediate fast excit-
atory synaptic transmission in the superficial dorsal horn (SDH)
of the spinal cord (lamina I and II). Lamina II contains a hetero-
geneous population of excitatory and inhibitory interneurons
that receive glutamatergic input from peripheral pain fibers and
from local interneurons (Todd, 2010). These lamina II cells shape
the excitatory output of lamina I neurons that project to the
brain, making them critical in the processing of noxious stimuli
(Wang et al., 2013; Yasaka et al., 2014). Following peripheral
injury or inflammation, SDH neurons exhibit changes in surface
AMPAR expression (Park et al., 2009; Kopach et al., 2011) that
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Significance Statement
In the brain, transmembraneAMPAR regulatory proteins (TARPs) critically determine the functional properties of AMPARs, but
the contribution of these auxiliary subunits to AMPAR-mediated signaling in the spinal cord remains unclear. An increase in the
excitability of neurons within the superficial dorsal horn (SDH) of the spinal cord is thought to underlie heighted pain sensitivity.
One mechanism considered to contribute to such long-lived changes is the remodeling of the ionotropic AMPA-type glutamate
receptors that underlie fast excitatory synaptic transmission in the SDH.Herewe show that the TARP-2 (stargazin) is present in
SDH neurons and is necessary in a form of inflammatory pain-induced plasticity, which involves an increase in the prevalence of
synaptic calcium-permeable AMPARs.
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are thought to contribute to central sensitization and heightened
pain sensitivity (Latremoliere and Woolf, 2009).
AMPARs are tetrameric assemblies formed from the subunits
GluA1–4 (Traynelis et al., 2010). In the SDH, themost abundant
AMPAR subunits are GluA1 and GluA2 (Hartmann et al., 2004;
Nagy et al., 2004; Polga´r et al., 2008). Although the existence of
GluA2-lacking, calcium-permeable (CP), AMPARs has been ob-
served in specific SDH neurons of young animals (Nagy et al.,
1994; Engelman et al., 1999; Tong andMacDermott, 2006),many
of the AMPARs in mature SDH neurons contain GluA2 subunits
(Nagy et al., 2004; Polga´r et al., 2008), rendering them calcium
impermeable (CI-AMPARs) (Katano et al., 2008). By contrast,
following peripheral injury or inflammation, CP-AMPARs are
upregulated at synaptic (Katano et al., 2008; Vikman et al., 2008;
Park et al., 2009; Chen et al., 2013) and potentially extrasynaptic
(Kopach et al., 2011) sites in SDH neurons. Such plasticity may
occur via NMDAR-dependent activation of protein kinase C and
subsequent phosphorylation of GluA2 (Park et al., 2009) and
GluA1 (Wang et al., 2011). Indeed, block of CP-AMPARs (Sorkin
et al., 1999) or the genetic deletion of GluA1 attenuates the de-
velopment of hyperalgesia, whereas deletion of GluA2 has the
opposite effect (Hartmann et al., 2004), suggesting that CP-
AMPAR expression is important in pain-related plasticity.
The functional properties of AMPARs depend not only on
their subunit composition but also on the presence of associated
auxiliary proteins. Of these, the transmembrane AMPAR regula-
tory proteins, classified as Type I (-2, -3, -4, and -8) or Type
II (-5 and -7) transmembrane AMPAR regulatory proteins
(TARPs), have received particular attention (Jackson and Nicoll,
2011b). TARPs influence the trafficking, pharmacology, channel
gating, and conductance of AMPARs (Coombs and Cull-Candy,
2009; Jackson and Nicoll, 2011b) and are implicated in synaptic
plasticity (Rouach et al., 2005; Tomita et al., 2005a; Jackson and
Nicoll, 2011a).
In the SDH of the spinal cord, immunolabeling has revealed
the presence of multiple TARP isoforms (Larsson et al., 2013).
Although the precise role of different TARPs in excitatory trans-
mission within the SDH has not been explored, knockdown of
-2 has been shown to lessen the severity of hyperalgesia (Tao et
al., 2006), possibly by preventing the increased surface expression
of CP-AMPARs (Guo et al., 2014). Moreover, polymorphisms in
the -2 geneCACNG2 have been associated with susceptibility to
chronic pain in humans (Nissenbaum et al., 2010).
Usingpharmacological approaches, immunohistochemistry and
patch-clamp recording from SDH neurons in acute spinal slices
from wild-type (wt) and -2-lacking stargazer (stg/stg) mice, we
show thatmost lamina II neurons express -2-associated AMPARs.
In these cells, EPSCs arising from local inputs, but not those arising
fromperipheralpain fibersactivatedbycapsaicin,wereattenuated in
stg/stgmice. In addition, we found that the presence of -2 is neces-
sary for CP-AMPAR plasticity in amodel of inflammatory hyperal-
gesia. Our studies establish an important role for -2 in shaping
dorsal horn excitability in both normal and pathological pain states.
Materials andMethods
Animals.Experimentswere performedusing tissue frommale and female
wt (C57BL/6), stargazer (stg/stg), and GAD65-eGFPmice, postnatal days
21 and 30 (P21-P30). Both stg/stg and GAD65-eGFP mice were on a
C57BL/6 background. The former were bred from/stgmice and iden-
tified based on their characteristic phenotype (head tossing and ataxic
gate). Phenotypic identification was confirmed by genotyping (Letts et
al., 1998). GAD65-eGFP mice (Lo´pez-Bendito et al., 2004) were main-
tained as homozygotes. All procedures for the care and treatment ofmice
were in accordance with the Animals (Scientific Procedures) Act 1986.
Western blots. CNS tissue was rapidly dissected in ice-cold PBS and
placed in RIPA lysis buffer (Thermo Scientific) with protease inhibitor
(Roche) and 1% IgPal detergent (Sigma). Volumes of lysis buffer were
adjusted for the source of tissue (spinal cord 250l; cerebellum or cortex
1000 l; hippocampus 250 l). Tissue was lysed by applying 20–30
strokes with a Dounce homogenizer. Following gentle rotation at 4°C for
1 h, samples were ultracentrifuged at 35,000 rpm for 35 min at 4°C.
Pellets were discarded, and the protein content of the supernatant was
measured using a Bradford assay (Bio-Rad). Samples were diluted to
equal concentrations (8 mg/ml) and reacted with equal volumes of 2
Laemmli buffer (Sigma) at 65°C for 15 min. A total of 80 g of protein
was separated in a 30% polyacrylamide Tris glycine gel and transferred
onto nitrocellulose paper. Blots were blocked for 1 h in PBS containing
4% milk and 0.05% Tween and reacted with primary antibodies over-
night at 4°C. Following several washes, blots were then incubated with
1:1000HRP-conjugated secondary antibody in blocking solution for 1 h.
Blots were washed and protein bands were detected using a chemilumi-
nescent assay ( Pierce Thermo Scientific), imaged with a digital camera
(Bio-Rad). Protein sizes were interpolated from a standard ladder
(Sigma).
Immunohistochemistry. Mice were deeply anesthetized with an intra-
peritoneal injection of ketamine (100 mg/kg)/xylazine (10 mg/kg) and
perfused transcardially with ice-cold PBS followed by 4% (w/v) formal-
dehyde in PBS. Brains and spinal cords were removed and incubated
overnight at 4°C in 4% formaldehyde. The following day, tissues were
exposed to a series of increasing sucrose concentrations (10%, 20%, and
30% w/v). Tissue was embedded in a cutting compound consisting of
11% polyvinyl alcohol and 5% carbowax and frozen in dry ice before
sectioning. Cryosections (20 m) were adhered to charged glass slides
and stored at20°C. All spinal cord sections were transverse, from L3 to
L6. Cerebellar sections were sagittal, and hippocampal sections were cor-
onal. Before immunolabeling, slides were washed in PBS.
Antigen retrieval was tested for all antibodies under varying durations
of pepsin exposure, as described previously (Watanabe et al., 1998; Nagy
et al., 2004). Briefly, slideswere incubated in 0.4% (w/v) pepsin (Dako) in
0.2 M HCl at 37°C. Seven to 10 min of pepsin treatment proved optimal
for AMPARs and -2, whereas -7 and -8 antibodies appeared to label
best without pepsin treatment (Table 1). Samples were blocked and per-
meabilized for 1 h in PBS containing the following: 10% serum, 0.5%
Triton, and 0.5% BSA. The source of the serum was matched to the
species in which the secondary antibodies were raised. Slides were incu-
bated in blocking solution containing primary antibody overnight at 4°C.
The next day, sections were washed and treated with fluorescent second-
ary antibodies in blocking solution. After washing, sections were treated
with DAPI (Thermo Scientific, 1:1000) for 10 min, dried, and mounted
in ProLongGold antifade (Thermo Scientific). To label lamina II, biotin-
linked IB4 (Thermo Scientific) (10 g/ml) was coincubated with the
primary antibodies, whereas Avidin 555 (2 g/ml) (Thermo Scientific)
was coincubated with secondary antibodies. The following day sections
were imaged using a Leica TCS SPE confocal microscope.
Antibodies. Details regarding the primary antibodies are provided in
Table 1. We tested each TARP antibody by running Western blots on
lysates fromHEKcells expressing eachTARP isoform independently. For
Western blots, we used HRP-conjugated secondary antibodies raised in
goat: anti-mouse (Santa Cruz Biotechnology 2005, 1:1000), anti-guinea
pig (Santa Cruz Biotechnology 2438, 1:1000), and anti-rabbit (Rockland
611–1302, 1:4000). For immunohistochemistry, we used secondary an-
tibodies conjugated to Alexa dyes (488, 555, and 647) raised against
rabbit, mouse, guinea pig, chicken, and goat (for example, see Thermo
Scientific, A-11008). All anti-rabbit, -mouse, -guinea pig, and -chicken
fluorescent antibodies were raised in goat whereas anti-goat antibodies
were raised in donkey.
Preparation of spinal cord slices for electrophysiological recording. Spinal
cords were rapidly dissected and sectioned in ice-cold slicing solution,
which contained the following (in mM): 120 K-gluconate, 15 KCl, 0.05
EGTA, 20 HEPES, 4 pyruvate, 25 glucose, 10 Na ascorbate, 0.05 D-AP5
(pH 7.4, bubbled with 100%O2). Sections (400m)were obtained from
L3-L6 spinal cord using a Campden vibrotome (7000 smz) with a ce-
ramic blade. Slices were then heated in recovery solution (35°C; bubbled
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with 95%O2, 5%CO2) for 30–60minbefore recording; this solutionwas
similar to that used for whole-cell recordings (see below), except it con-
tained high Mg2 (6 mM) and low Ca2 (0.5 mM).
Whole-cell recordings. All recordings were performed at room temper-
ature (22°C-25°C). Slices were transferred to a submerged recording
chamber and perfused with a solution containing the following (in mM):
125 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 25 glucose, 2 CaCl2, and
1 MgCl2. Slices were viewed using a Zeiss Axioscop with a 4 objective,
and the substantia gelatinosa of the horn identified. Under 40magni-
fication with differential interference contrast imaging, lamina II was
identified as a translucent band between the relatively darker laminae (I
and III). Cells within the outer half of lamina II with soma diameters
between 9 and 12 m were targeted for recording.
For voltage-clamp recordings, the intracellular solution contained the
following (in mM): 128 CsCl, 2 NaCl, 1 CaCl2, 10 HEPES, 10 EGTA, 10
TEA-Cl, 2 MgATP, and 1 N-(2,6-dimethylphenylcarbamoylmethyl) tri-
ethylammonium bromide (QX314; Tocris Bioscience) (adjusted to pH
7.4 with CsOH). In experiments where rectification was measured, 100 M
spermine tetrahydrochloride (Sigma) was included in the pipette solution.
For current-clamp recordings, the intracellular solution contained the fol-
lowing (inmM): 120 K-gluconate, 10 KCl, 40HEPES, 0.5 EGTA, 3MgCl2, 2
NaATP, and 0.3 NaGTP (adjusted to pH 7.4 with KOH). Series resistance,
input capacitance, and input resistance were determined by measuring the
current elicited by a 5mVhyperpolarizing voltage step. The series resistance
remaining after 60%–80% compensation was typically8 M. Recordings
were made with an Axopatch 200A amplifier, low-pass filtered (Bessel 10
kHz), and sampled at 20 kHz using a Digidata 1440A with pClamp10 soft-
ware (Molecular Devices).
AMPAR-mediated currents were pharmacologically isolated by the
addition of 10 M 2-(3-carboxypropyl)-3-amino-6-(4 methoxyphe-
nyl)pyridazinium bromide (SR-95531; gabazine), 10M strychnine, and
50 M D-AP5. To activate C-fibers, slices were exposed to 0.1 M capsa-
icin (diluted from 50 mM stock in DMSO). TTX (1 M) was included in
the recording solution when recording miniature EPSCs (mEPSCs), or
the responses to bath applied agonists [25 M AMPA or 10 M CNQX,
both with 100 M cyclothiazide]. Quantal EPSCs (qEPSCs) were evoked
in the presence of Sr 2 (replacement of CaCl2 with 5 mM SrCl2) using a
thin-walled borosilicate glass micropipette filled with extracellular solu-
tion (0.5–1 M) placed in the dorsal horn 50 m away from the re-
corded cell. The minimal voltage and frequency necessary to produce
reliable responses were used (typically 5–30 V, 0.1 ms, 0.05–0.2 Hz).
Recordings from GABAergic interneurons. Lamina II GAD65-eGFP-
positive cells were identified under epifluorescence using LED illumina-
tion (pE-100; CoolLED). To confirm the identity of each recorded
GAD-positive cell, we included biocytin (0.3% w/v, Thermo Scientific)
in the pipette solution. At the end of the recording, the holding potential
was switched to 0 mV and the pipette was slowly retracted. Slices were
immediately placed in 4% PFA in PBS and left overnight at 4°C. Follow-
ing three 10 min washes in PBS, slices were incubated in Triton (0.1%)
and Avidin 555 (2g/ml) for 4 h at 4°C. Slices were then washed, reacted
with DAPI (5 g/ml), dried, and mounted in ProLong Gold antifade
overnight. The following day, confocal images of cells were taken with a
63 objective. GFP expression in the filled neurons was confirmed by
detection of fluorescence and/or GFP immunoreactivity.
Synaptic immunolabeling and analysis. When using our transcardial
fixation protocol (see above), the extent of pepsin treatment required to
reveal -2 labeling often proved too harsh to preserve the labeling of
presynaptic markers. Therefore, to reduce the fixation time and improve
antigen retrieval, we fixed brain slices prepared as in our whole-cell re-
cording experiments. In some cases, slices were incubated in 4% PFA in
PBS (1 h), resectioned using a cryostat, and treated with pepsin (1 min),
as described above. In most cases, however, we adopted a light fixation
protocol using carbodiimide (Moffett et al., 1993) rather than PFA, al-
lowing us to avoid the use of pepsin altogether. Slices were fixed for 1.5 h
in a solution containing 6% carbodiimide, 1 mM n-hydroxyl succinim-
ide, and 200 mM sucrose. All blocking solutions, antibody solutions, and
mounting media were identical to those used with PFA. Following fixa-
tion, slices were washed and incubated in blocking/permeablization so-
lution for 2 h. Slices were treated with primary antibodies for 48 h,
washed, and then treated with secondary antibodies for 24 h. Confocal
images (1024  1024 pixels; 56.2  56.2 m) of synaptic puncta were
acquired with a 63, 1.3 numerical aperture, oil-immersion objective
under 3 zoom. For analysis, Z-stacks consisting of six images (each 252
nm apart) were deconvolved using ImageJ plugins developed by the Bi-
ological Imaging Group (http://bigwww.epfl.ch/). Theoretical point
spread functionswere generated using the Born andWolf algorithm (PSF
Generator plugin) and deconvolution performed using the Landweber
algorithm (Deconvolutionlab plugin). A maximum intensity projection
of the deconvolved images with contrast enhancement was used to detect
synaptic puncta. Data from pepsin and carbodiimide treated tissue were
pooled.
The proportion of postsynaptic puncta contacting or juxtaposed to
any number presynaptic puncta (and vice versa) was determined using
CellProfiler software (version 2.1.1; http://cellprofiler.org/) (Carpenter
et al., 2006; Kamentsky et al., 2011). We used the adaptive thresholding
object detection algorithm to identify puncta separately on each imaging
channel. To detect overlapping or adjacent presynaptic or postsynaptic
puncta, object edges were uniformly expanded by one pixel and overlaid
with the objects of the opposing channel for comparison. An object
contacting any number of objects on the opposing channel was consid-
ered positive for “overlap”. A control image, rotated 180 degrees, was
used to estimate the chance likelihood of object overlap (false positive
rate). This background value was subtracted to obtain the final values
reported in the text.
Table 1. Details of the primary antibodies used in this study and the requirement for antigen retrieval (pepsin treatment)a
Antigen Species Source Number Dilution (Western) Dilution (IHC) Pepsin (IHC)
-2 Guinea pig M. Watanabe — 1:500 — —
-2b Rabbit Cell Signaling Technology 8511 — 1:200 Yesc
-3 Guinea pig M. Watanabe — 1:500 — —
-4 Rabbit Abcam ab81107 1:500 — —
-5 Rabbit M. Watanabe — 1:500 — —
-7 Rabbit Frontiers Institute Af720 1:500 1:500 No
-8 Rabbit Frontiers Institute Af1000 1:2000 1:1000 No
GluA1 Rabbit Abcam ab31232 — 1:500 Yes
GluA2 Mouse Millipore MAB397 1:500 1:500 Yes
c-Fos Goat Santa Cruz Biotechnology sc-52-G — 1:100 No
Actin Mouse Abcam ab3280 1:5000 — —
GFP Chicken Abcam Ab13970 — 1:500 No
CGRPb Mouse Sigma C7113 — 1:400 No
vGluT1b Guinea pig Synaptic Systems 135 304 — 1:400 No
vGluT2b Guinea pig Millipore AB2251 — 1:4000 No
aIHC, Immunohistochemistry.
bUsed for imaging synapses (see Materials and Methods).
cPepsin used for-2 labeling of PFA fixed tissue but not with carbodiimide fix (synaptic imaging).
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Induction of peripheral inflammation. Peripheral inflammation was in-
duced by complete Freund’s adjuvant (CFA), an oil emulsion containing
1 mg/mlMycobacterium tuberculosis (Sigma). Mice received a unilateral
subcutaneous intraplantar injection of 20l CFA. For histological detec-
tion of c-Fos, mice were perfused transcardially with 4% PFA 1.5 h after
CFA injection, when c-Fos expression was highest. Electrophysiological
recordings were performed 24 h after CFA injection. At the time of slice
preparation (see below), the side of the slice ipsilateral to the injection
wasmarked with a small notch in the whitematter of the ventral horn for
identification during recordings.
Analysis of electrophysiological data. All EPSC analysis was performed
using Igor Pro (version 6.34a, Wavemetrics) with Neuromatic (version
2.8v, http://www.neuromatic.thinkrandom.com/). For EPSC detection,
records were digitally filtered offline at 1 kHz and a threshold crossing
procedure used (Kudoh and Taguchi, 2002). The thresholds were typi-
cally 8 pA at60 or 60 mV or 6 pA at 40 mV. For each cell, the average
EPSC waveform was constructed from all events (aligned at their onset)
and its rise time (RT20%–80%) and decay (single exponential deacy) mea-
sured. The rectification of EPSCs was assessed by dividing the peak con-
ductance of the average event at positive potentials (40 or 60 mV) by the
conductance at60mV, assuming a reversal potential of 0mV (RI40/60
or RI60/60). The rectification of whole-cell currents evoked by bath
application of AMPA was calculated as the ratio of the slope conduc-
tances (RIslope; 35 to 40 mV/55 to 60 mV). As the tonic whole-cell
currents induced by bath application of CNQX were sometimes small,
the holding current wasmeasured using an automated procedurewritten
in Igor Pro, as described previously (Rigby et al., 2015). Briefly, an all-
point histogram was constructed from 1 s segments of the complete
record (15min). For each histogram, a single-sidedGaussianwas fitted
to the most-positive current values to remove the influence of phasic
synaptic events, and the peak of the Gaussian was taken as the mean
current value.
Peak-scaled nonstationary fluctuation analysis (psNSFA). The weighted-
mean single-channel conductance of synaptic receptors underlying qEPSCs
andmEPSCswasmeasured using psNSFA (Traynelis et al., 1993). The peak
of the average event was scaled to the peak of each individual event and
subtracted. The residual noise was spilt into 30 bins of equal amplitude, and
the average variance was computed within each bin and plotted against the
corresponding average amplitude. The parabolic relationship between vari-
ance and amplitude was fitted using the following equation:
PS
2  iI 
I2
Np
 B
2, (1)
where PS
2 is the peak-scaled variance, I is the mean current, i is the
weighted mean single-channel current, NP is the number of channels
open at the peak of the EPSC, and B
2 is the background variance.
Statistics and data presentation. Summary data are presented in the text
as mean SEM. from n cells. Analyses of single datasets were conducted
using a two-sided one-sample t test, with a null hypothesis that the mean
equals zero. Comparisons involving only two datasets were performed
using a two-sided two-sample Welch t test that does not assume equal
variance. Analyses involving data from three or more groups were per-
formed using either two-way ANOVA (Welch heteroscedastic F test),
followed by pairwise comparisons using two-sided Welch two-sample t
tests with Holm’s sequential Bonferroni correction, or Kruskal-Wallis
one-way ANOVA, followed by pairwise Wilcoxon rank sum tests with
Holm’s sequential Bonferroni correction. Paired data were compared
with a two-way “split plot” ANOVA followed by two-sided Welch two-
sample paired t tests. Exact p values are presented to two significant
figures, except when p 0.0001. Differences were considered significant
at p  0.05. Statistical tests were performed using R (version 3.3.2; R
Foundation for Statistical Computing; http://www.r-project.org/) and R
Studio (version 1.0.136; RStudio). The results of omnibus tests are given
in the text or figure legends, with pairwise p values reported in the text
and designated by asterisks in the figures.
Results
TARP expression in the spinal cord
Using Western blots, we initially examined the expression of the
complete family of TARPs (-2, -3, -4, -5, -7, and -8) in
spinal cord homogenates from wt and stg/stg mice. To validate
our antibodies, we also used tissue from three other brain regions
(hippocampus, cerebellum, and cortex) for which TARP expres-
sion has been well characterized (Fig. 1A). We detected protein
bands for -2, -4, and -8 in spinal cord but found no evidence
for -3, -5, or -7. As expected, -2 was also present in all other
brain regions examined, with the strongest expression observed
in cerebellum (Tomita et al., 2003). The specificity of the -2
antibody was confirmed by the absence of signal in spinal cord
samples from stg/stgmice (Fig. 1B). We found -4 in spinal cord
as well as cortex and hippocampus, with a lower level in cerebel-
lum (Tomita et al., 2003). We initially detected little or no -8 in
spinal cord or cerebellum, despite a strong signal in hippocampus
and a slightly weaker signal in cortex, as reported previously (To-
mita et al., 2003). However, in separate immunoblot experiments
where we examined spinal cord samples following a longer expo-
sure, -8 was clearly present in tissue from both wt and stg/stg
mice (Fig. 1B). Failure to detect -3, -5, and -7 in spinal cord
did not reflect failure of the antibodies, as -3 was detected in
cortex and, to a lesser extent, in hippocampus. Moreover, both
-5 and -7 were detected in cerebellum, as previously described
(Fukaya et al., 2005; Soto et al., 2009; Yamazaki et al., 2010). Of
note, aside from the loss of -2, we detected no obvious change in
the expression of other TARPs in spinal cord samples from stg/stg
mice.
We next examined the spatial distribution of TARPs and
AMPARs within the dorsal horn by performing immunohisto-
chemistry on transverse spinal cord sections (Fig. 1C–F). To
identify lamina II, we used Isolectin B4 (IB4), which labels a thin
band of nonpeptidergic C-fibers in this lamina (Silverman and
Kruger, 1990). Following antigen retrieval with pepsin (see Ma-
terials andMethods; Table 1), we were able to detect immunore-
activity for the AMPAR subunits GluA1 and GluA2, which
showed relatively intense expression in the in spinal cord SDH.
No obvious abnormalities were apparent in the laminar pattern-
ing of these AMPAR subunits in sections from stg/stg mice (Fig.
1C).Within the SDH and deeper laminae of wtmice, we detected
punctate immunoreactivity for -2 (Fig. 1D) (Tao et al., 2006)
but no immunoreactivity for -7 (Fig. 1E). However, we found
pronounced -7 expression in sagittal sections of cerebellum,
with the strongest signal in Purkinje cell bodies and themolecular
layer, confirming the effectiveness of our protocol (Yamazaki et
al., 2010). As expected, immunolabeling for -8 was readily de-
tected in the hippocampus (Fig. 1F). In the spinal cord, immu-
noreactivity for -8 appeared punctate in lamina I and relatively
diffuse in outer lamina II (Fig. 1F), as previously described
(Larsson et al., 2013). We were unable to conclusively determine
the expression pattern of -3, -4, or -5. The whole-serum -4
antibody used inWestern blots appeared to label nonspecifically in
spinal cord sections. It also failed to label brain sections, as did our
antibodies for -3 and -5 (data not shown). Nonetheless, both our
immunohistochemical and Western blot data indicate the clear
presence of -2 in the SDH, and a lesser but clear presence of -8.
TARP -2 is associated with functional AMPARs in lamina
II neurons
Given the suggestion that -2 plays a role in hyperalgesia (Tao et
al., 2006), we sought to determine whether Type I TARPs in SDH
neurons are associated with functional AMPARs. We examined
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neurons in the outer region of lamina II, as these smaller excit-
atory cells were more likely to permit high-resolution whole-cell
voltage-clamp recordings. We used the classical AMPAR blocker
CNQX to identify TARP-associated AMPARs, as it acts as a par-
tial agonist at AMPARs associated with Type I TARPs (-2, -3,
-4, and -8) (Menuz et al., 2007; Bats et al., 2012). Because
CNQX-evoked currents are generally small compared with those
evoked by glutamate (Menuz et al., 2007), we included the posi-
tive allostericmodulator cyclothiazide (100M) in our solutions.
We made recordings in the presence of TTX, gabazine, strych-
nine, and D-AP5 to block voltage-gated Na channels, GABAA
receptors, glycine receptors and NMDA receptors, respectively.
As expected, bath application of CNQX reversibly blocked
mEPSCs (Fig. 2A–C) in lamina II neurons from wt mice. CNQX
also produced clear inward currents (29.5 4.2 pA, n	 24, p
0.0001 vs zero) that returned to baseline on washout (Fig. 2A).
CNQX currents were also detectable in neurons from stg/stg mice
lacking-2, but thesewere ofmuch smaller amplitude than those in
wt (4.0 1.4 pA, n	 16, p	 0.014 vs zero, p 0.0001 vs wt) (Fig.
2B,D). This striking attenuation suggests that -2 is normally the
predominant Type I TARP associated with AMPARs in lamina II
interneurons.
Approximately 20%–30% of lamina II neurons are inhibitory
(Polga´r et al., 2003; Santos et al., 2007; Yasaka et al., 2010), the
majority being GABAergic (Zeilhofer et al., 2012).We next asked
whether -2 is associated with AMPARs in these GABAergic in-
terneurons. To address this, we measured CNQX-induced currents
in cells identified in mice expressing GFP under the glutamic acid
decarboxylase (GAD65) promoter (Lo´pez-Bendito et al., 2004). In
all GFP-positive cells where firing was examined (by depolarizing
current injection;n	10,datanot shown),weobserveda tonic firing
pattern characteristic of GABAergic interneurons (Santos et al.,
2007; Punnakkal et al., 2014). InGFP-positive cells, CNQXevoked a
mean current of 5.11.5pA (n	12,p	0.0060 vs zero),markedly
less than that in lamina II neurons of wt mice (p  0.0001; Fig.
2C,D), raising thepossibilityof cell-typedifferences inTARPexpres-
sion within lamina II.
TARP -2 plays an important role inmany central neurons by
regulating both AMPARproperties and their trafficking (Jackson
and Nicoll, 2011b). The reduced magnitude of CNQX-evoked
currents in stg/stg lamina II neurons indicates the presence of
fewer Type I TARP-associated AMPARs at the cell surface. How-
ever, if cell surface expression of AMPARs in these neurons re-
quires -2, then one would also expect a reduced response to
AMPA itself. When we compared whole-cell current responses
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Figure 1. TARP expression in the spinal cord. A, Immunoblots comparing tissue expression
of -2, -3, -4, -5, -7, and -8 in homogenates of spinal cord (sc), hippocampus (hc),
cerebellum (cb), and cortex (ctx). Note the presence of -2 and -4 in spinal cord.
4
B, Immunoblots comparing wt and stg/stg spinal cord. Note the expected absence of -2.
Increased exposure times (compared with A) were used for -3, -5, -7, and -8 and re-
vealed the presence of-8 in bothwt and stg/stg samples. The approximatemolecularweights
of the various TARPs (in kDa) were as follows:-2, 35;-3, 32;-4, 45;-5, 27;-7, 28;-8,
47. Actin (41 kDa) served as a loading control. C–F, Confocal images (maximum intensity pro-
jections) of representative tissue sections immunolabeled for TARPsandAMPARs.C, Dorsal horn
of the spinal cord. Left, differential interference contrast images overlaid with fluorescence
signal for the lamina II-specific marker IB4 (red). Middle and right panels, Similar pattern of
expression for AMPAR subunits GluA1 (green) and GluA2 (cyan) in sections fromwt and stg/stg
mice.Here, and in followingpanels, all spinal cord images are transverse and shown in the same
orientation. D, Dorsal; V, ventral;M,medial; L, lateral. Scale bar, 100m.D, Comparison of-2
expression in the dorsal horn of wt and stg/stg mice. Left, DAPI staining (blue). Middle, -2
(green). Right, Overlay of IB4 (red) and-2 (green). E, Left,-7 expression (green) in cerebel-
lum (cb); molecular layer (ML), Purkinje cell layer (PCL), and granule cell layer (GCL). Middle,
-7 (green) in spinal cord. Right, Overlay of IB4 (red) and -7 (green). F, Left, -8 (green) in
hippocampus (hc). Scale bar, 500m.Middle,-8 (green) in dorsal horn. Right, Overlay of IB4
(red) and-8 (green).
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with bath-applied AMPA (20 M) in lamina II neurons from
stg/stg and wt mice, we found them to be of similar amplitude
(1.5  0.2 vs 1.6  0.2 nA, n 	 5 and n 	 7 stg/stg and wt,
respectively; p	 0.93) (Fig. 2E). This implies that -2, although
normally associated with AMPARs in these cells, is not essential
for their surface expression. In the absence of -2, surface recep-
tors may be TARPless (Bats et al., 2012) or associated with other
auxiliary subunits able to compensate for its loss (Menuz et al.,
2008).
Quantal EPSCs are attenuated in stg/stg lamina II neurons
To determine whether -2 regulates synaptic AMPARs in lamina
II neurons, we next compared the synaptic currents in cells from
wt and stg/stg mice. To exclude possible presynaptic effects, we
examined qEPSCs evoked in the presence of strontium (Goda
and Stevens, 1994). In these conditions, local electrical stimula-
tion promoted an asynchronous burst of qEPSCs in both wt and
stg/stg (Fig. 3A,B). In cells from stg/stg mice, the average qEPSC
amplitude was approximately halved (from 22.0 1.5 to 12.5
0.7 pA; n	 9 and 16, p	 0.00076) (Fig. 3C–E). This reduction in
qEPSC amplitude could reflect a decrease in the number, con-
ductance, or open probability of synaptic AMPARs. Using peak
scaled psNSFA (Traynelis et al., 1993), we found that the
weightedmean single-channel conductance of synaptic AMPARs
was reduced in stg/stg cells compared with wt (from 37.9 2.9 to
24.3 2.7 pS; n	 8 and n	 10; p	 0.0097) (Fig. 3F–H). There
was no difference in the estimated number of receptors open
at the qEPSC peak (9.4  1.1 vs 9.2  0.8; p 	 1.0). Thus, the
reduced qEPSC amplitude in stg/stg appears to reflect reduced
mean channel conductance rather than impaired AMPAR
trafficking.
The frequency of evoked qEPSCs was reduced in stg/stg cells
compared with wt (from 6.6 1.0 to 3.3 0.4Hz, n	 9 and n	
16, respectively; p	 0.038). Although this difference could reflect
an increase in the proportion of smaller amplitude events falling
below the detection threshold, we cannot exclude a change in the
number of synaptic inputs or our ability to stimulate these inputs
(which may additionally vary depending on the size and position
of the stimulating electrode). Interestingly, in stg/stg cells, we
found no change in the qEPSC 20%–80% rise time (wt 0.38 
0.04 ms, stg/stg 0.41  0.05 ms; p 	 1.0) or decay (3.4  0.3 vs
3.0  0.2 ms; p 	 0.68). This is reminiscent of the situation
previously described for qEPSCs and mEPSCs in cerebellar
stellate cells from stg/stg mice, which are also reduced in am-
plitude but show only a modest (Jackson and Nicoll, 2011a) or
no (Bats et al., 2012) change in decay kinetics. Although it is
unclear whether the synaptic AMPARs remaining in lamina II
neurons from stg/stg mice are associated with a TARP other
than -2 or are TARPless, our results indicate that -2 is nor-
mally associated with AMPARs at synapses receiving locally
evoked excitatory input.
TARP -2 involvement in synaptic transmission is input-
specific
We next considered whether -2 is associated with AMPARs at
synapses in those lamina II neurons that receive input from pe-
ripheral pain fibers. In individual cells from wt and stg/stg mice
we first recorded mEPSCs under “basal” (control) conditions,
where most events are thought to arise from non–C-fiber inputs
(Yang and Li, 2001), and then in the presence of capsaicin to
increase selectively the frequency of events arising from TRPV1-
expressing C-fiber terminals (Yang et al., 1998). In slices from
both wt and stg/stg mice, capsaicin (0.1 M) increased the fre-
quency of mEPSCs in approximately half the neurons tested (wt
17 of 28; stg/stg 13 of 33) (Fig. 4A,B). In the “capsaicin-sensitive”
cells, mEPSC frequency was increased from 0.64  0.13 Hz to
4.22 1.35 Hz in wt (p	 0.024) and from 0.61 0.23 to 2.57
0.80 Hz in stg/stg (p 	 0.017). Considering only capsaicin-
sensitive cells, the average amplitude of control (“basal”)
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Figure 2. CNQX-evoked currents are reduced in lamina II neurons of stg/stg mice. A,
Representative whole-cell current (60 mV) in a wt lamina II neuron evoked by bath
application of CNQX (10 M) in the presence of cylothiazide (100 M). Bottom trace
(colored), Isolated holding current (1 s bins) (see Materials and Methods). B, Same as A,
but for a neuron from an stg/stgmouse. C, Same as A, but for a GAD65-positive neuron (wt
mouse). D, Summary data for CNQX-evoked currents. Box-and-whisker plots indicate the
median (line), 25th and 75th percentile (box), range of data within 1.5 interquartile
range (whiskers), and mean (white circles). Superimposed filled circles represent individ-
ual cells. A one-way ANOVA indicated a significant difference among the three groups
(F(2,32)	 16.97, p 0.0001). ***p 0.001 (pairwise differences). E, Summary data for
AMPA-evoked currents. Box-and-whisker plots as in E.
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Figure3. Evoked qEPSCs in lamina II neurons fromwt and stg/stgmice.A, Representative recording fromawtmouse of electrically evoked qEPSCs in the presence of SrCl2 (60mV). Black arrow
indicates the timeof stimulation. Inset, Expansion of indicated area. Bottom, Raster plot showing individual qEPSCs (vertical ticks) over 16 stimulation trials. Overlaid histogram shows the frequency
of eventswithin 200ms bins averaged over the 16 trials.B, Same asA, but for a neuron froman stg/stgmouse. C, Histogramof qEPSC amplitudes (same cell asA). Gray represents background noise.
Inset, Average mEPSC waveform. D, Same as C, but for the stg/stg neuron in B. E, Summary data for qEPSC amplitudes. F, Current-variance relationship for the same cell as A. The weighted mean
conductance ()wasdetermined fromtheparabolic fit (gray) of thedata.G, SameasF, but for the stg/stgneuron inB.H, Summarydata for estimated single-channel conductance. Box-and-whisker
plots as in Figure 2. **p 0.01. ***p 0.001.
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mEPSCswas less in stg/stg than inwt (15.9 1.8 vs 22.4 1.5 pA,
n	 13 and n	 15; p	 0.00081) (Fig. 4C–E), consistent with the
view that -2 normally plays a role at the putative non–C-fiber
synapses from which “basal” mEPSCs are thought to originate.
By contrast, the amplitudes of capsaicin-induced mEPSCs were
similar in stg/stg and wt (23.2 1.8 vs 22.7 1.4 pA; p	 0.74)
(Fig. 4C–E). Furthermore, psNSFA of the capsaicin-induced
mEPSCs indicated no difference inmean channel conductance of
synaptic AMPARs in stg/stg and wt cells (26.9 2.9 vs 27.7 2.2
pS, n	 13 and n	 16; p	 0.83; Fig. 4F). Together these obser-
vations suggest either that -2 is not normally associated with
AMPARs at TRPV1-expressing C-fiber synapses or that other
auxiliary subunits are present and can substitute for -2. In those
cells where capsaicin failed to alter mEPSC frequency, the ampli-
tude of the “basal” mEPSCs was similar in stg/stg and wt (18.3
1.7 vs 17.5 1.0 pA, n	 20 and n	 11; p	 1.0) and therewas no
difference in their frequency (0.95  0.38 vs 0.55  0.08 Hz;
p	 0.86).
-2 is preferentially expressed at non–C-fiber synapses
To examine further our proposition that postsynaptic elements
containing -2 were associated with non–C-fiber inputs, we im-
aged synaptic puncta in lamina II of spinal cord slices from 6 wt
mice colabeled with antibodies against -2 and presynaptic
marker proteins. We examined ROIs of 56.2 56.2 m (3000
m2) in outer lamina II and used an object detection algorithm
(see Materials and Methods) to determine the proportion of -2
puncta that partially overlapped or were juxtaposed to presynap-
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Figure4. Basal, but not capsaicin-induced,mEPSCs are reduced in lamina II neurons from stg/stgmice.A, Representative recording ofmEPSCs froma lamina II neuron of awtmouse showing the
effect of bath-applied capsaicin (0.1M). Inset (bottom), Changes in mEPSC frequency (20 s bins). B, Same as A, but for a neuron from an stg/stg mouse. C, Average mEPSC waveforms from the
recording inA, togetherwith cumulative probability plots for the amplitudes of control and capsaicin-inducedmEPSCs.D, Same as C, but for the neuron inB. E, Summary data formEPSC amplitudes.
A two-way “split plot” ANOVA indicated no significant main effect of genotype (F(1,26)	 2.96, p	 0.098), a significant main effect of capsaicin treatment (F(1,26)	 14.73, p	 0.00071), and a
significant interaction between genotype and capsaicin treatment (F(1,26)	 13.88, p	 0.00095). F, Summary data for capsaicin-induced mEPSCs showing the weighted mean single-channel
conductance from psNSFA. Box-and-whisker plots as in Figure 2. ***p 0.001.
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tic markers. In slices colabeled for -2 and the peptidergic C- and
A	-fiber marker calcitonin gene-related peptide (CGRP) (Nagy
et al., 2004), we identified a total of 3246 -2-positive puncta and
2370 CGRP-positive puncta (11 ROIs summed from six mice).
The mean diameter of -2 and CGRP puncta was 390 and 448
nm, respectively. Adjusting for the chance probability of object
overlap (see Materials and Methods), only 4.3  0.9% of -2
puncta contacted CGRP-containing puncta. This indicates that
only a small fraction of -2 puncta are contacted by peptidergic C-
and A	-fibers. The corresponding analysis showed that 4.8 1.1%
of CGRP terminals contacted -2 puncta (Fig. 5A).
We also colabeled separate slices for -2 and the vesicular
glutamate transporters vGluT1 and vGluT2,which are thought to
belong to mutually exclusive classes of non–C-fiber terminals
(Todd et al., 2003, but see Li et al., 2003) (Fig. 5B,C). As previ-
ously reported (Li et al., 2003), the expression of vGluT1 in outer
lamina II was lower than that observed in deeper laminae. Nev-
ertheless, at high magnification, we observed abundant vGluT1
puncta in this region. We identified a total of 1416 vGluT1-
positive puncta (four ROIs from 4mice) with amean diameter of
503 nm and 2213 vGluT2-positive puncta (seven ROIs from 5
mice) with a mean diameter of 439 nm. Adjusting for the chance
probability of object overlap, 38.5  9.7% of -2 puncta were
judged as contacting vGluT1-expressing terminals and 7.8 
1.6% were judged as contacting vGluT2-expressing terminals.
Kruskal-Wallis one-way ANOVA indi-
cated a significant difference in the prob-
ability of -2 overlap among the CGRP,
vGluT1, and vGluT2 groups (H2	 10.47,
p	 0.0053) with pairwise Wilcoxon rank
sum tests indicating p 	 0.028 for CGRP
versus vGluT1 and p 	 0.055 for CGRP
versus vGluT2. Together, these data sug-
gest that -2 is preferentially adjacent to
presumed non–CGRP-expressing, vGluT1-
tk;1positive terminals, in keeping with our
proposition that-2 is localizedprimarily at
non–C-fiber synapses in lamina II.
Peripheral inflammation promotes a
switch from CI- to
CP-AMPARs at C-fiber synapses
There is compelling evidence that expo-
sure to noxious stimuli triggers upregula-
tion of CP-AMPARs in SDH neurons that
is thought to play a crucial role in hyper-
algesia (Park et al., 2009; Kopach et al.,
2011; Chen et al., 2013). However, it is
unclear which synaptic inputs are affected
and which TARPs are involved in these
changes. To investigate this, we used a
common model of chronic inflammatory
pain by performing intraplantar injec-
tions of CFA (Pearson, 1956). We were
able to confirm the effectiveness of our
CFA injection by detecting the presence of
a selectively ipsilateral increase in the ex-
pression of the immediate early gene
c-Fos in the lumbar region (L3-L6) of
SDH (Hossaini et al., 2014) (Fig. 6A).
To test lamina II neurons for CFA-
induced plasticity, we recorded from the
corresponding ipsilateral dorsal horn and
first examined whole-cell currents generated by bath applied
AMPA (Fig. 6B). We made use of the fact that, when spermine is
included in the patch pipette, CP-AMPARs display a characteris-
tic inwardly rectifying current-voltage relationship that allows
them to be readily identified (Bowie andMayer, 1995; Kamboj et
al., 1995; Koh et al., 1995). Previous studies had suggested that
CFA treatment triggers an increase in rectification of AMPA-
evoked currents in a tonically firing subset of lamina II neurons
(Kopach et al., 2011). However, in our recordings with bath-
applied AMPA, we found no evidence of an increase in rectifica-
tion in cells from CFA-treated mice (RIslope naive 0.73  0.05,
CFA 0.85 0.03, n	 7 and n	 10; p	 0.13) (Fig. 6C). Similarly,
the rectification of locally evoked qEPSCs remained unchanged
(RI40/60 1.02 0.05 vs 1.00 0.04, n	 7 and n	 9; p	 0.96)
(Fig. 6D,E). We next examined the capsaicin-induced mEPSCs
thought to arise from C-fiber inputs. Following peripheral in-
flammation, these exhibited a marked increase in rectification
(RI60/60 decreased from 0.90 0.04 to 0.59 0.04, n	 9 naive
and n 	 10 CFA; p 	 0.00016) (Fig. 7A,B,E). By contrast, in
capsaicin-insensitive cells, the CFA treatment failed to alter rec-
tification (RI60/60 0.93  0.05 vs 0.86  0.04, n 	 5 naive and
n 	 8 CFA; p 	 0.64). Together, these data suggest that the
increased prevalence of CP-AMPARs that accompanies periph-
eral inflammation occurs specifically at pain fiber synapses.
A
B
C
Figure 5. Synaptic expression pattern of-2 in outer lamina II.A, Confocal images of immunolabeled-2 (left), CGRP (middle), and
overlay (right). Red represents-2. Green represents CGRP. Overlay, Arrow indicates an example punctumpositive for-2. Single arrow-
head indicates example punctumpositive for the presynapticmarker CGRP. Double arrowhead indicates an example of adjacent or over-
lapping-2 andCGRPpuncta. In the individual images, the correspondingarrowsandarrowheads are colored: red represents-2; green
represents CGRP; yellow represents overlap. B, Same as A, but for the presynaptic protein vGluT1. C, Same as A, but for the presynaptic
protein vGluT2. Images shown represent3%of the area used for quantification of puncta. Scale bar, 2m.
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Upregulation of CP-AMPARs at C-fiber synapses requires -2
Behavioral studies have shown that -2 knockdown before the
application of peripheral noxious stimuli lessens the severity of
hyperalgesia (Tao et al., 2006; Guo et al., 2014). To test whether
the upregulation of CP-AMPARs that we observed at C-fiber
synapses following CFA treatment was dependent on -2, we
repeated these experiments using stg/stg mice. As in wt animals,
A
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Figure 6. CFA treatment fails to alter AMPAR rectification in lamina II neurons. A, Top,
Representative immunolabeling (maximum intensity projection confocal images) showing
CFA-induced c-Fos expression (green) in ipsilateral SDH 1.5 h following hindpaw injection in a
wtmouse. Scale bar, 100m. Insets, Enlarged view from indicated area.White arrow indicates
an example of a c-Fos-expressing cell. Bottom, Same as top, but with overlaid labeling for the
lamina II marker IB4 (red). B, Representative current-voltage relationships from lamina II neu-
rons from a naive (light blue) and a CFA-treated mouse (dark blue) obtained 24 h after treat-
ment. Currentswere evoked by AMPA (20M) in the presence of cyclothiazide (100M). Inset,
Voltage ramp protocol (60 to 40 mV). C, Summary data for RIslope values (40/60 mV).
D, Representative averageof electrically evokedqEPSCs in SrCl2 recorded from lamina II neurons
of a naive mouse and a CFA-treated mouse. RI40/60 values indicated. E, Summary RI40/60
data for qEPSCs. Box-and-whisker plots as in Figure 2.
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Figure 7. CFA treatment increases rectification of capsaicin-induced mEPSCs in lamina II
neurons from wt but not stg/stg mice. A, Representative averaged capsaicin-induced mEPSCs
fromanaivewt neuron; RI value indicated. Inset, Normalized amplitude histograms for the two
voltages (60 mV gray,60 mV black). B, Same as A, but for a lamina II neuron from a CFA-
treatedwtmouse. C, Same as A, but for a neuron from a naive stg/stgmouse.D, Same as A, but
for a neuron from a CFA-treated stg/stg mouse. E, Summary of RI60/60 data for capsaicin-
evoked mEPSCs. Box-and-whisker plots as in Figure 2. Two-way ANOVA showed no effect of
genotype (F(1,28)	 1.59, p	 0.22), a significant effect of CFA treatment (F(1,28)	 11.39, p	
0.0022), and a significant interaction between genotype and treatment (F(1,28)	 9.44, p	
0.0047). ***p 0.001.
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CFA injection increased c-Fos expression in the ipsilateral SDH
(n 	 3 mice; data not shown). However, in these stg/stg mice,
CFA caused no change in the rectification of capsaicin-induced
mEPSCs (RI60/60, 0.85 0.06 vs 0.88 0.05, n	 6 naive and 7
CFA; p	 0.75) (Fig. 7C–E). This suggests that-2 is necessary for
the CFA-induced upregulation of CP-AMPARs at these synapses
in lamina II neurons.
Despite the necessity for -2 in our CFA-induced plasticity, in
the naive animals, we found no difference between wt and stg/stg
mice in the rectification of their capsaicin-inducedmEPSCs (p	
0.47) (Fig. 7E). Neitherwas the rectification ofwhole-cell AMPA-
evoked currents or that of evoked qEPSCs changed (p	 0.68 and
p 	 0.96, respectively; data not shown). Together, these results
suggest that the absence of-2 does not enhance the prevalence of
CP-AMPARs in lamina II neurons of naive mice. This is in
striking contrast with cerebellar stellate cells, where increased
AMPAR rectification is seen in stg/stg mice (Jackson and Ni-
coll, 2011a; Bats et al., 2012), and suggests that cell type-
dependent differences in the AMPAR proteome influence the
outcome of -2 deletion.
Discussion
Our studies provide functional evidence for the involvement
of an AMPAR auxiliary subunit in shaping excitatory trans-
mission in spinal cord pain pathways. We establish that -2
contributes to the excitatory synaptic currents of lamina II
neurons in an input-specific manner and is critical in CP-
AMPAR plasticity at C-fiber synapses following peripheral in-
flammation.
TARP expression in lamina II neurons
Our immunolabeling data showed -2 to be present in SDH lam-
ina II of mouse, as previously observed in rat (Tao et al., 2006;
Guo et al., 2014). We found that CNQX, a partial agonist at
AMPARs associated with Type I TARPs (Menuz et al., 2007),
induced a current in most lamina II neurons, and this was sub-
stantially reduced in neurons from stg/stg mice. Additionally,
evoked qEPSCs were attenuated in stg/stg mice. These observa-
tions provide clear evidence for the presence of -2-associated
AMPARs at synapses in these neurons. The fact that currents
evoked by bath applied AMPA were not reduced in stg/stg mice
might therefore appear unexpected. However, it is unlikely that
activation of extrasynaptic and synaptic receptors would reveal
differences if only a small subset of AMPARs (such as those at
specific synaptic inputs) were impaired.
Although the CNQX-induced current in lamina II neurons
was much smaller in stg/stg mice than in wt, the presence of a
small residual current suggests that at least some AMPARs in
these neurons may associate with Type I TARPs other than -2.
These aremost likely -4 or -8, as we detected protein for these in
spinal cord samples. Nonspecific labeling prevented us from exam-
ining thedistributionof-4histologically, but its presence in lamina
II of the rat (albeit without clear colocalization with AMPARs) has
previously been reported (Larsson et al., 2013). We detected punc-
tate immunoreactivity for -8 in lamina I and relatively diffuse la-
beling in lamina II, as also previously seen in rat (Larsson et al.,
2013). Although it seems likely that -8 associates with functional
AMPARs in lamina II neurons, studies in -8 knock-out mice
(Rouachet al., 2005)wouldbenecessary to address its significance in
SDH pain circuitry.
Do Type II TARPs (-5 and -7) play any role in lamina II
neurons? This is of interest as there is previous evidence for an
association of these TARPs with CP-AMPARs (Soto et al., 2009;
Bats et al., 2013). As CNQX does not act as an agonist at -7-
associated AMPARs (Bats et al., 2012), it cannot be used to pro-
vide evidence for their presence. However, our failure to detect
immunolabeling for -5 or -7 would argue against a role for
either. Interestingly, -7 has been detected in lamina II of the rat,
albeit not colocalized with AMPARs (Larsson et al., 2013).
Whether this reflects a genuine species difference in TARP ex-
pression remains to be determined.
Although many of the lamina II neurons we examined are
likely to have been excitatory (Todd and Sullivan, 1990; Polga´r et
al., 2003; Santos et al., 2007), we found that inhibitory interneu-
ronswithin this lamina differed in theirCNQXresponses. Studies
in other regions of the CNS have shown that GABAergic neurons
can exhibit robust currents in response to CNQX (Menuz et al.,
2007; Bats et al., 2012). In spinal cords from wt mice, GAD65-
positive GABAergic neurons displayed, on average, smaller
CNQX-induced current than the mixed population of neurons
(expected to be predominantly excitatory). Although we cannot
exclude a simple difference in AMPAR number, this observation
raises the possibility of differential TARP expression. If this were
the case, TARPs could influence the balance of excitation and
inhibition within the SDH neuronal network (Braz et al., 2014),
and their identification may aid in differentiating between SDH
neuron types, an ongoing challenge in the field (Graham et al.,
2007).
Input-dependent TARP expression
In lamina II neurons from stg/stgmice, the amplitudes of qEPSCs
evoked by local stimulationwere reduced. Likewise, in a subset of
lamina II cells receiving input from capsaicin-sensitive C-fibers,
the amplitudes of basal mEPSCs, thought to arise from non–C-
fiber inputs (Yang and Li, 2001), were reduced. However,
capsaicin-induced mEPSCs (from C-fibers) within these same
cells were unaltered in stg/stg mice. The most parsimonious
explanation for these findings is that both qEPSCs and basal
mEPSCs arise from the same inputs, which activate receptors
associated with -2, whereas the synapses formed by TRPV1-
expressing C-fibers on the same cell typically lack -2. In keeping
with this view, we also found that -2-containing synapses in
lamina II were rarely contacted by C-fibers (identified with
CGRP or IB4) but exhibited a clear association with vGluT1-
expressing non–C-fiber terminals. Thus, our functional and im-
munolabeling data are both consistent with the notion that -2 is
expressed preferentially at non–C-fiber synapses.
Input-specific CP-AMPAR plasticity
There is compelling evidence that AMPAR-mediated excitatory re-
sponses are augmented, and the CP-AMPAR contribution in-
creased, in central sensitization (Latremoliere and Woolf, 2009).
Moreover, blocking CP-AMPARs can limit the development of al-
lodynia following peripheral injury (Sorkin et al., 1999) and can
reverse hyperalgesia following peripheral inflammation (Sorkin et
al., 2001). However, despite an established role for CP-AMPARs in
pain hypersensitivity, surprisingly little is known about which cell
types and synapses are modified. We found that CFA treatment in-
creased the prevalence of CP-AMPARs at synapses formed by
capsaicin-sensitive, TRPV1-expressing, C-fibers. Such a change was
absent from other inputs on the cell that could be activated by focal
stimulation, implying that the CFA-induced plasticity was synapse
specific.
The extent to which homosynaptic, rather than heterosynap-
tic changes, contribute to central sensitization at activated pain
fibers is unclear (Latremoliere andWoolf, 2009). Repeated stim-
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ulation of pain fibers is known to potentiate their postsynaptic
responses (Ikeda et al., 2006), a prerequisite for homosynaptic
plasticity. In line with such homosynaptic plasticity, intraplantar
injection of capsaicin increases the relative abundance of GluA1
at a specific subset of C-fiber synapses in rat SDHneurons, favor-
ing nonpeptidergic synapses over peptidergic ones (Larsson and
Broman, 2008). However, it is of note that activity-dependent
heterosynaptic changes have also been observed in SDH neurons
(Thompson et al., 1993; Naka et al., 2013). Our finding that plas-
ticity was present at synapses receiving input from TRPV1-
expressing terminals, but not at other synapses on these cells,
supports the view that homosynaptic plasticity plays a role in
inflammatory pain.
The importance of -2 for central sensitization
Knockdown of -2, before inflammation (Tao et al., 2006) or
prior to plantar incision (Guo et al., 2014), has previously been
shown to limit the severity of hyperalgesia. In the latter study,
knockdown of -2 also precluded pain-induced increases in
GluA1 surface expression.Our finding that peripheral inflamma-
tion no longer elicits an increase in CP-AMPARs at C-fiber syn-
apses in stg/stgmice implies that -2 is required for the enhanced
expression and localization of synaptic CP-AMPARs in this form
of plasticity. In the brain, -2 is known to dynamically influence
AMPAR trafficking (Tomita et al., 2005b; Bats et al., 2007; Opazo
et al., 2010). Moreover, loss of -2 has been suggested to impair
certain forms of synaptic plasticity involving CP-AMPARs (Jack-
son and Nicoll, 2011a). It therefore seems plausible that -2
within lamina II neurons plays an active role in mediating plas-
ticity at C-fiber synapses, perhaps through changes in its interac-
tion with PSD-95 and other postsynaptic proteins, as is observed
with AMPARs following their pain-induced phosphorylation
(Park et al., 2009).
The unusual arrangement, in whichC-fiber AMPARs lack -2
in naive control mice but require -2 to undergo plasticity,
suggests that induction of hyperalgesia involves -2-lacking
AMPARs being replaced by -2-containing AMPARs. Interest-
ingly, consistent with this hypothesis, hyperalgesia has been as-
sociated with increased coimmunoprecipitation of GluA1 with
-2 in dorsal horn tissue extracts (Guo et al., 2014). It is notewor-
thy that the regulation of calcium-impermeable (CI) and CP-
AMPARs by TARPs appears to be cell-type dependent. For
example, whereas -2 plays a role in the expression of CI-
AMPARs in cerebellar stellate (Jackson and Nicoll, 2011a; Bats et
al., 2012) and granule cells (Studniarczyk et al., 2013), in oligo-
dendrocyte precursor cells (Zonouzi et al., 2011) it is required for
the insertion of CP-AMPARs, similar to that observed in dorsal
horn neurons. Clearly, it would nowbe of considerable interest to
identify other auxiliary proteins that may account for the dispar-
ity between different cell types.
Our studyestablishes thatTARP-2 serves a cell type- and input-
specific role within lamina II of the dorsal horn. However, many
questions remain aboutwhere precisely-2 andother auxiliary sub-
units are expressed within nociceptive pathways. Although genetic
techniques have only begun to tease apart dorsal horn cell types and
their connectivity, recent advances showpromise (Peirs et al., 2015).
It is noteworthy that an understanding of TARP expression in noci-
ceptive circuitrymay reveal novel therapeutic targets, in that TARPs
endow AMPARs with a unique pharmacology. For example, two
antagonists have recently been developed that selectively block
AMPARs associated with -8 (Gardinier et al., 2016; Maher et al.,
2016).DevelopmentofotherTARP-selectivedrugsmay increase the
resolutionofAMPAR-targetedpain therapies and aid in treating the
maladaptive aspects of pain while retaining the basic nociceptive
signaling necessary for survival.
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